![]() |
||||||||||||||||||
|
|
Do Neurons Get Overexcited Too? A Perspective on Learning and Epilepsy Anita Bandrowski
There are several classes of "listening" or receptor proteins positioned to "hear" the information coming from their neighbor cells. These receptor proteins can be divided into two major classes. The first is ionotropic, which is responsible for detecting the presence of a signal, and the other is metabotropic, which is responsible for modifying the information. The two-tiered information processing system allows very important information to be preferentially treated so that many systems become involved in its processing. For example, the sight of your mother while you are hiding her birthday present would be a piece of information that would elicit multiple behavioral effects such as a limbic response, vasodialation in the face (flushing) or an increase in heart rate. To measure the information that is "heard" by a neuron, it is possible to visualize, using a microscope, a living neuron and inserting a very small electrode into it. The electrode can "listen" in on the ongoing electrical activity, and this activity can be recorded using a high-powered amplifier and a computer. Various pharmacological tools, i.e. drugs, can bind to receptor molecules and modify their activity, which has secondary effects on the ongoing neuronal activity. Using these types of tools, I have found that metabotropic glutamate receptors, a metabotropic receptor that "hears" signals being passed via the glutamate molecule, are involved in learning. Activation of these receptors can modify the response to the original signal, enough to cause a long lasting "memory" of that signal. This memory manifests itself as a response that is larger in size than the original response to the same signal. By studying the rat brain, I am presently interested in determining whether the increase in response size, which is elicited by metabotropic glutamate receptors, can ever get large enough to trigger an epileptic episode. If so, I can then ask whether these receptors participate in ongoing seizures in epileptic mice and eventually in epileptic patients. If it could be determined that the metabotropic glutamate receptors are involved in epilepsy, then these receptors become a new target for intelligent drug design. Unfortunately, there are many epileptics who do not respond well to conventional medication, and therefore development of new classes of drugs adds choices for doctors and patients. |
||||||||||||
| Modified 15 January 2003 * Contact
Us |